Wearables May Boost T2D Mobility - Takeaways - MDSpire
From the Journals

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

  • By

  • Kathryn Wighton

  • May 11, 2026

  • 4 min

Share

  • 1

    Study involved 58 outpatients with type 2 diabetes and kidney disease.

  • 2

    Intervention led to a significant increase in 6-minute walk distance.

  • 3

    Wearable devices recorded activity data for exercise guidance.

  • 4

    Glycated hemoglobin decreased by 0.89 percentage points.

  • 5

    No serious adverse events were reported during the study.

  • 6

    Limitations included study design and sample size.

  • 7

    Recommendations for future research on device impact.

Original Source(s)

Wearables May Boost T2D Mobility

  • by Kathryn Wighton

  • May 11, 2026

Related Content

Ancient DNA Tracks 10,000 Years of Selection

Large dataset shows widespread genetic changes shaping modern traits and disease risk

  • May 12, 2026

  • 3 min
Remote Diet Support Studied in Diabetes

WhatsApp-based low-carbohydrate nutrition education was linked to short-term glycemic, weight, and medication-use improvements in a small primary care trial

Frontline Pharma: Sarah O’Keeffe

Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients